<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000306490"><TermName>idiopathic myelofibrosis</TermName><TermPronunciation>(IH-dee-oh-PA-thik MY-eh-loh-fy-BROH-sis)</TermPronunciation><TermDefinition><DefinitionText>A progressive, chronic disease in which the bone marrow is replaced by fibrous tissue and blood is made in organs such as the liver and the spleen, instead of in the bone marrow. This disease is marked by an enlarged spleen and progressive anemia. Also called agnogenic myeloid metaplasia, chronic idiopathic myelofibrosis, myelosclerosis with myeloid metaplasia,  and primary myelofibrosis.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710160" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;idiopathic myelofibrosis&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710159" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mielofibrosis idiopática&quot;" language="es" id="_4"/><SpanishTermName>mielofibrosis idiopática</SpanishTermName><SpanishTermDefinition><DefinitionText>Enfermedad evolutiva, crónica en la que la médula ósea es reemplazada por tejido fibroso y la sangre se produce en órganos tales como el hígado y el bazo, en vez de la médula ósea. Esta enfermedad se caracteriza por el agrandamiento del bazo y anemia evolutiva. También se llama metaplasia mieloide agnógena, mieloesclerosis con metaplasia mieloide, mielofibrosis idiopática crónica,  y mielofibrosis primaria.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-05-23</DateFirstPublished><DateLastModified>2007-04-26</DateLastModified></GlossaryTerm>
